Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Increasing HPV Vaccination in Community-Based Pediatric Practices
Not Available
N/A
Hull, Pamela
NCT03399396
VICCPED1999
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers
Miscellaneous
Miscellaneous
Miscellaneous
N/A
Tindle, Hilary
NCT03603496
VICCMD19100
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients with Cirrhosis
Liver
Liver
This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced ultrasound imaging, may help find and diagnose liver cancer.
Liver
N/A
Planz, Virginia
NCT03318380
VICCGI19104
The Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) for Bladder Cancer Study.
Bladder
Bladder
Bladder
N/A
Scarpato, Kristen
NCT03933826
VICCURO19105
Construction and Validation of an Oral Health Screening Tool in Head and Neck Cancer Survivors Who Received Chemotherapy or Radiotherapy
Multiple Cancer Types
Head/Neck,
Supportive Care
N/A
Smith, Derek
VICCSUPP19107
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Hematologic
Hematologic
This study evaluates the use of Brimonidine tartrate nanoemulsion eye drop solution in the treatment of ocular Graft Verses Host Disease (oGVHD). Two thirds of participants will receive Brimonidine and one third will receive ophthalmic buffered saline (placebo).
Hematologic
III
Tran, Uyen
NCT03591874
VICCBMT19132
Barriers and Facilitators to Hispanic Participation in Cancer Clinical Trials: A Pilot Study
Miscellaneous
Miscellaneous
Miscellaneous
N/A
Davis, Amanda
VICCMD2023
A Study of MK-6482 Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
Bladder
Bladder
The primary objective of this study is to compare MK-6482 to everolimus with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) and to compare everolimus with respect to overall survival (OS). The hypothesis is that MK-6482 is superior to everolimus with respect to PFS and OS.
Bladder
III
Beckermann, Kathryn
NCT04195750
VICCURO19114
Patient Perspectives about Discussing Financial Toxicity in Head and Neck Cancer
Head/Neck
Head/Neck
Head/Neck
N/A
Langerman, Alexander
VICCSUPP19116
